Biofidelity
PrivateLast Round
VC Round
Apr 3, 2024
Total Funding Raised
$35.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biofidelity operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a VC Round in April 2024.
Biofidelity is a genomics technology company that develops and commercializes molecular diagnostic assays to improve access to precision medicine for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biofidelity Comparables
Compare Biofidelity with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biocartis | 79% | |
| EntroGen, Inc. | 78% | |
| Roche Holding | 76% |
For institutional investors. Book with your work email.
Biofidelity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 3, 2024 | ||||
| Series A Extension | Feb 1, 2022 | ||||
| Series A | Aug 20, 2020 | ||||
| Seed | Sep 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biofidelity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BlueYard Capital | VC Round, Series A Extension, Series A |
| Longwall Venture Partners | Series A, VC Round, Series A Extension, Seed |
| Octopus Ventures | VC Round, Series A Extension |
| SBI Investment Co., Ltd. | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 278% MoM.
- Jan 17, 2025
Integrates Aspyre Lung assay into clinical trial services.
For institutional investors. Book with your work email.
Biofidelity Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biofidelity's valuation, stock price, and market status.
Is Biofidelity a public or private company?
Biofidelity is a private company.
What is the current stock price of Biofidelity?
Biofidelity is a private company, so its shares have no public market price. Caplight tracks Biofidelity's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biofidelity worth (valuation)?
Valuation information for Biofidelity is not publicly available.
Can I buy Biofidelity stock?
Biofidelity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biofidelity's last funding round?
Biofidelity's most recent funding round was VC Round on April 3, 2024.
Who are the main investors in Biofidelity?
Key investors in Biofidelity include BlueYard Capital, Octopus Ventures.
Will Biofidelity IPO soon?
No public IPO plans have been announced for Biofidelity.
How can I track Biofidelity secondary market activity?
Caplight tracks bids, offers, and trades in Biofidelity's shares on secondary markets.